Speakers

Tigran Arzumanov, PhD, MBA has been working in the area of clinical research sales & marketing since 2004 and has extensive experience in commercial aspects of both pharmaceutical research services and eClinical solutions.

Liora Bosch, has been working at Omrix as a biostatistician for the past 4 years and has broad-based experience in study design and data analysis. In her former role, Liora filled the position of a clinical data manager, overseeing multisite clinical trials across the US and EU. 

Divya Chadha Manek is the Industry Business Development Manager for the NIHR Clinical Research Network (CRN). Divya’s role is to maintain strategic relationships with Global and UK life sciences companies. 

Frederic Deutsch is a statistician with over 22 years of experience in statistics/biostatistics and data mining. Frederic joined Biostats Statistical Consulting Ltd. in 2008 after working as a biostatistician in the Global Biostatistics Unit, Innovative R&D Division at Teva Pharmaceutical Industries Ltd.

Dr. Lisa Deutsch has accumulated over 20 years of experience in biostatistics, gaining expertise in varied medical research fields including medical devices as well as anti-viral/anti-infectious agents, oncology, ophthalmology, orthopedics, and gastrointestinal, among others.

Catherine Ela, PhD, is currently the Head of the clinical trials department at the Ministry of Health. Prior to that she held the position of director of the  clinical trials medical devices and advanced therapies unit and was a pharmacist at the Pharmaceutical Department at the Ministry of Health.

Matt J. Ellefson
SURVIVEiT® - Founder & CEO
Sioux Falls, SD

Bosmat Friedman is the Head of Clinical and Regulatory Services of ProMedoss, Inc. She has been working as a regulatory consultant since 2007 initially as a consultant in Push-Med and subsequently as the CEO of MJ RAC. 

Sara Furie MSc is a chemist and a regulatory affairs executive and has been working in the pharmaceutical industry in regulatory affairs and clinical drug development for the past 20 years.

Kenneth A. Getz is the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise.  

Miguel A. Hernandez, MD and postgraduate studies in the field of medical Bioethics. He is currently working as the Clinical Operations & Safety Manager at MD-CLINICALS. 

Omer Iqbal, MD, FACC, FESC. is a  Professor of Pathology and Ophthalmology at Loyola University Medical Center in Maywood, Illinois, USA.  He is an elected fellow in the American College of Cardiology and European Society of Cardiology.  

Olivier specializes in the area of regulatory issues and has developed significant expertise in the life sciences and healthcare sectors, in particular as concerns medical devices, pharmaceutical and phytopharmaceutical products, and cosmetics. For over 15 years, he has assisted his clients in the sector with regulatory issues and environmental questions. 

Danny Lieberman is a serial entrepreneur and one of top 5 experts in the world in data loss prevention. 

Dr. Moshe Neuman, Ph.D. serves as the President & CEO of Bio-Medical Research Design Ltd. (B.R.D) founded in 1998. He bears over eighteen years of experience in the fields of pharmaceutical, medical device research & development, and regulatory compliance. His regulatory expertise includes both FDA, and EU/ICH regulations.

As counsel of our Life Sciences practice, Fabien Roy focuses his practice at Hogan Lovells on advising clients on European Union and national regulatory matters applicable to medical devices, medicinal products and combination products throughout their entire life cycle.

Anat Sakov is a statistician and a senior manager with over 20 years of experience in applied statistics in industry, consulting, research and teaching. In the past 7 years Anat is managing a group of statisticians responsible for the statistical support in several therapeutic areas in the branded R&D Division of Teva Pharmaceuticals. 

Ms. Strauss-Levy has more than 20 years’ experience in the pharma industry, serving as Vice President of clinical, IP and regulatory affairs in global, dually listed (NASDAQ & TASE) pharmaceutical firms. Holds specific expertise in Orphan Drug space, Diabetes T1/2, Respiratory, Oncology, Vaccination and Medical-Cannabis drug development as well as IPO processes and Intellectual property.    

1993 to Present Managing Director, TechnoSTAT ltd, Raanana Israel 

Dr. Arthur Weinstein is Clinical Professor Emeritus of Medicine, Georgetown University and Past Associate Chairman, Department of Medicine at MedStar Washington Hospital Center. He is currently Chief Medical Officer, Exagen Diagnostics, Inc., Vista, CA.  He is board certified in Rheumatology and Diagnostic Laboratory Immunology. 

Listed as an expert in regulatory issues on EU Life Sciences law by Who's Who Legal: Life Sciences 2017 Elisabethann Wright has been practising in the Life Sciences sector for over 30 years in both private practice and international institutions.